CUSIP 55234L105COMLYRAQ2 2025
41 filings · latest Aug 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ifp Advisors, Inc | 300 | $26 |
| 4 | Nov 14, 2024 | Venrock Healthcare Capital Partners II, L.P. | 13G/A | 1.8% | 1.20M | SEC |
| 5 | Nov 14, 2024 | Samsara Biocapital, L.P. | 13G/A | 5.0% | 3.28M | SEC |
| 6 | Nov 14, 2024 | Nantahala Capital Management, LLC | 13G/A | 1.1% | 702.1K | SEC |
| 7 | Nov 14, 2024 | Point72 Asset Management, L.P. | 13G/A | — | — | SEC |
| 8 | Nov 14, 2024 | Vestal Point Capital, LP | 13G/A | — | — | SEC |
| 9 | Aug 15, 2024 | Perceptive Advisors LLC | 13D/A | 19.5% | 12.76M | SEC |
| 10 | Feb 14, 2024 | Pura Vida Investments, LLC | 13G/A | 3.1% | 1.61M | SEC |
See the full Schedule 13D/13G history for Lyra Therapeutics Inc.
Unlock full history